- Home
- DRMA vs SSY Comparison
DRMA vs SSY Comparison
Compare DRMA & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRMA
- SSY
- Stock Information
- Founded
- DRMA 2014
- SSY 1959
- Country
- DRMA United States
- SSY United States
- Employees
- DRMA N/A
- SSY N/A
- Industry
- DRMA Biotechnology: Pharmaceutical Preparations
- SSY Hospital/Nursing Management
- Sector
- DRMA Health Care
- SSY Health Care
- Exchange
- DRMA Nasdaq
- SSY Nasdaq
- Market Cap
- DRMA 6.1M
- SSY 5.5M
- IPO Year
- DRMA 2021
- SSY N/A
- Fundamental
- Price
- DRMA $1.25
- SSY $0.99
- Analyst Decision
- DRMA Strong Buy
- SSY
- Analyst Count
- DRMA 1
- SSY 0
- Target Price
- DRMA $6.00
- SSY N/A
- AVG Volume (30 Days)
- DRMA 465.7K
- SSY 55.3K
- Earning Date
- DRMA 03-20-2025
- SSY 02-12-2025
- Dividend Yield
- DRMA N/A
- SSY N/A
- EPS Growth
- DRMA N/A
- SSY N/A
- EPS
- DRMA N/A
- SSY 0.14
- Revenue
- DRMA N/A
- SSY $31,233,000.00
- Revenue This Year
- DRMA N/A
- SSY N/A
- Revenue Next Year
- DRMA N/A
- SSY N/A
- P/E Ratio
- DRMA N/A
- SSY $6.97
- Revenue Growth
- DRMA N/A
- SSY N/A
- 52 Week Low
- DRMA $1.00
- SSY $0.53
- 52 Week High
- DRMA $7.62
- SSY $1.91
- Technical
- Relative Strength Index (RSI)
- DRMA 52.68
- SSY 56.84
- Support Level
- DRMA $1.00
- SSY $0.82
- Resistance Level
- DRMA $1.28
- SSY $1.04
- Average True Range (ATR)
- DRMA 0.09
- SSY 0.09
- MACD
- DRMA 0.01
- SSY 0.01
- Stochastic Oscillator
- DRMA 74.07
- SSY 80.81
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.